|
| Interplay between TRα1 and Wnt signaling: A dangerous liaison |
|
https://doi.org/10.18632/oncotarget.25807
Sheue-Yann Cheng
|
| 31939-31940 |
|
| Thyroid hormone and intestinal tumor: a Wnt connection |
|
https://doi.org/10.18632/oncotarget.25822
Yun-Bo Shi
|
| 31941-31941 |
|
| Cancer and the junkyard chromosome: how repeat DNA sequence on chromosome 19 influences risk of malignant disease |
|
https://doi.org/10.18632/oncotarget.25873
Anna M. Rose
|
| 31942-31944 |
|
| UHRF1 suppression promotes cell differentiation and reduces inflammatory reaction in anaplastic thyroid cancer |
|
https://doi.org/10.18632/oncotarget.10674
Bi-Cheng Wang, Guo-He Lin, Bo Wang, Min Yan, Bin He, Wei Zhang, An-Kui Yang, Zi-Jie Long, and Quentin Liu
|
| 31945-31957 |
|
| Ponatinib exerts antiangiogenic effects in the zebrafish and human umbilical vein endothelial cells via blocking VEGFR signaling pathway |
|
https://doi.org/10.18632/oncotarget.24110
Nana Ai, Cheong-Meng Chong, Weiting Chen, Zhe Hu, Huanxing Su, Guokai Chen, Queenie Wing Lei Wong, and Wei Ge
|
| 31958-31970 |
|
| The assessment of correlation and prognosis among 18FFDG uptake parameters Glut1 pStat1 and pStat3 in surgically resected nonsmall cell lung cancer patients |
|
https://doi.org/10.18632/oncotarget.25865
Hayato Kaida, Koichi Azuma, Akihiko Kawahara, Eiji Sadashima, Satoshi Hattori, Shinzo Takamori, Jun Akiba, Kiminori Fujimoto, Axel Rominger, Takamichi Murakami, Kazunari Ishii, and Masatoshi Ishibashi
|
| 31971-31984 |
|
| Metabolomic analysis of uterine serous carcinoma with acquired resistance to paclitaxel |
|
https://doi.org/10.18632/oncotarget.25868
Manabu Seino, Tsuyoshi Ohta, Akiko Sugiyama, Hirotsugu Sakaki, Takeshi Sudo, Seiji Tsutsumi, Shogo Shigeta, Hideki Tokunaga, Masafumi Toyoshima, Nobuo Yaegashi, and Satoru Nagase
|
| 31985-31998 |
|
| Intensification of induction chemotherapy before consolidation chemoradiotherapy improves progressionfree survival and time without treatment in patients with locally advanced pancreatic cancers |
|
https://doi.org/10.18632/oncotarget.25877
Nicolas Williet, Thomas Di Bernardo, Chloé Vernet, Léa Saban Roche, Thierry Muron, Xavier Roblin, Nicolas Magne, and Jean-Marc Phelip
|
| 31999-32009 |
|
| PAR1 signaling on tumor cells limits tumor growth by maintaining a mesenchymal phenotype in pancreatic cancer |
|
https://doi.org/10.18632/oncotarget.25880
Cansu Tekin, Kun Shi, Joost B. Daalhuisen, Marieke S. ten Brink, Maarten F. Bijlsma, and C. Arnold Spek
|
| 32010-32023 |
|
| PD1 is expressed on exhausted T cells as well as virus specific memory CD8+ T cells in the bone marrow of myeloma patients |
|
https://doi.org/10.18632/oncotarget.25882
Anne-Marit Sponaas, Rui Yang, Even Holth Rustad, Therese Standal, Aud Solvang Thoresen, Camilla Dao Vo, Anders Waage, Tobias S. Slørdahl, Magne Børset, and Anders Sundan
|
| 32024-32035 |
|
| Combinatorial engineering of NTIMP2 variants that selectively inhibit MMP9 and MMP14 function in the cell |
|
https://doi.org/10.18632/oncotarget.25885
Valeria Arkadash, Evette S. Radisky, and Niv Papo
|
| 32036-32053 |
|
| Circulating microRNA636 is associated with the elimination of hepatitis C virus by ombitasvir/paritaprevir/ritonavir |
|
https://doi.org/10.18632/oncotarget.25889
Asahiro Morishita, Hirohito Yoneyama, Hisakazu Iwama, Koji Fujita, Miwako Watanabe, Kayo Hirose, Tomoko Tadokoro, Kyoko Oura, Teppei Sakamoto, Shima Mimura, Takako Nomura, Makoto Oryu, Takashi Himoto, Kunitada Shimotohno, and Tsutomu Masaki
|
| 32054-32062 |
|
| Wildtype p53 oligomerizes more efficiently than p53 hotspot mutants and overcomes mutant p53 gainoffunction via a dominantpositive mechanism |
|
https://doi.org/10.18632/oncotarget.25944
Dawid Walerych, Magdalena Pruszko, Lukasz Zyla, Michalina Wezyk, Katarzyna Gaweda-Walerych, and Alicja Zylicz
|
| 32063-32080 |
|
| The efficacy and safety of firstline therapies for preventing chronic postsurgical pain: a network metaanalysis |
|
https://doi.org/10.18632/oncotarget.22611
Jie Ning, Jing Luo, Zengdong Meng, Chong Luo, Gang Wan, Jie Liu, Sanrong Wang, Xingye Lian, ND Melgiri, Yang Sun, and Rongzhong Huang
|
| 32081-32095 |
|
| Correction: MicroRNA expression in pretreatment plasma of patients with benign breast diseases and breast cancer |
|
https://doi.org/10.18632/oncotarget.25979
Mirelle Lagendijk, Sepideh Saadatmand, Linetta B. Koppert, Madeleine M.A. Tilanus-Linthorst, Vanja de Weerd, Raquel RamÃrez-Moreno, Marcel Smid, Anieta M. Sieuwerts, and John W.M. Martens
|
| 32096-32096 |
|
| Correction: Genetically enhanced T lymphocytes and the intensive care unit |
|
https://doi.org/10.18632/oncotarget.25983
Tiberiu Tat, Huming Li, Catalin-Sorin Constantinescu, Anca Onaciu, Sergiu Chira, Ciprian Osan, Sergiu Pasca, Bobe Petrushev, Vlad Moisoiu, Wilhelm-Thomas Micu, Cristian Berce, Sebastian Tranca, Delia Dima, Ioana Berindan-Neagoe, Jianliang Shen, Ciprian Tomuleasa, and Liren Qian
|
| 32097-32097 |
